A Novel Mutation in EFNB1, Probably with a Dominant Negative Effect, Underlying Craniofrontonasal Syndrome

@article{Shotelersuk2006ANM,
  title={A Novel Mutation in EFNB1, Probably with a Dominant Negative Effect, Underlying Craniofrontonasal Syndrome},
  author={Vorasuk Shotelersuk and Pichit Siriwan and Surasawadee Ausavarat},
  journal={The Cleft Palate-Craniofacial Journal},
  year={2006},
  volume={43},
  pages={152 - 154}
}
Craniofrontonasal syndrome (CFNS) is an X-linked disorder whose main clinical manifestations include coronal craniosynostosis and frontonasal dysplasia. Very recently, CFNS was shown to be caused by mutations in EFNB1 encoding ephrin-B1, and 20 mutations have been described. We report a Thai woman with CFNS, in whom a novel mutation was discovered: c.685_686insG, in exon 5 of EFNB1. It is the first insertion and the most 3′ point mutation in EFNB1 reported to date. The mutation is expected to… 

Figures from this paper

The impact of CFNS-causing EFNB1 mutations on ephrin-B1 function
TLDR
Pathogenic mechanisms in CFNS manifestation include impaired ephrin-B1 signalling combined with cellular interference, and missense mutations located in the extracellular ephrine domain involved in Eph-ephrin-B 1 recognition and higher order complex formation are studied.
Craniofrontonasal Syndrome Caused by Introduction of a Novel uATG in the 5′UTR of EFNB1
TLDR
This study demonstrates, for the first time, the regulatory impact of uATG formation onEFNB1 levels and suggests that this should be the target region in molecular diagnosis of CFNS cases without pathogenic variants in the coding and splice sites regions of EFNB1.
Contiguous gene deletions involving EFNB1, OPHN1, PJA1 and EDA in patients with craniofrontonasal syndrome
TLDR
Although it is too early to predict the future cognitive performance of the two infant patients with contiguous gene deletions of OPHN1–EFNB1–PJA1, mild learning disabilities have been recognized in the older, third patient.
Phenotypes of craniofrontonasal syndrome in patients with a pathogenic mutation in EFNB1
TLDR
Patients with EFNB1 mutations have a clear phenotype and this study will facilitate genetic counseling of parents and patients, and contribute to the diagnostic and screening process of patients with suspected CFNS.
EFNB1 mutation at the ephrin ligand‐receptor dimerization interface in a patient with craniofrontonasal syndrome
TLDR
A CFNS patient with a novel EFNB1 missense mutation present at the interface betweenEFNB1 and its receptor proteins is reported, inferring that the Ser118Ile mutation may impede the protrusion of the G‐H loop, thereby disturbing Eph–Ephrin signal transduction.
Dissecting the molecular mechanisms in craniofrontonasal syndrome: differential mRNA expression of mutant EFNB1 and the cellular mosaic
TLDR
Expression of EFNB1 mRNA was studied by RT-PCR in fibroblast cultures established from CFNS female patients to suggest differential degradation of mutant EF NB1 transcripts by the nonsense-mediated mRNA decay pathway, further supporting the concept of cellular interference in CFNS.
Use of targeted next‐generation sequencing for molecular diagnosis of craniosynostosis: Identification of a novel de novo mutation of EFNB1
TLDR
This study performed targeted, massively parallel sequencing using a next‐generation sequencer, and identified a novel EFNB1 mutation, c.270_271delCA, in a Japanese female patient with craniosynostosis, determined to be de novo in origin.
Trio-Based Whole-Exome Sequencing Identifies a De novo EFNB1 Mutation as a Genetic Cause in Female Infant With Brain Anomaly and Developmental Delay
TLDR
EFNB1 mutation is considered for a child with schizencephaly, and further study focusing on phenotyping is required to understand the possible contribution of environmental impact and genetic modifier in the expression of EFNB1.
Specific missense mutations in FGFR 2 , p . ( Ser 252 Trp ) and p . ( Pro 253 Arg ) , can lead to the autosomal dominant Apert syndrome ( OMIM 101200 ) [
TLDR
The most common craniosynostosis syndromes are characterized followed by a description of the novel causes that were identified between January 2015 and December 2017.
Isolated Sagittal Synostosis in a Boy with Craniofrontonasal Dysplasia and a Novel EFNB1 Mutation
TLDR
Craniofrontonasal syndrome is a rare X-linked disorder that shows greater severity in females and is largely attributed to mutations in EFNB1 and a novel C to T mutation at nucleotide 466 (c.466C>T) in exon 1 ofEFNB1 for both boys.
...
...

References

SHOWING 1-8 OF 8 REFERENCES
Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome.
TLDR
It is concluded that mutations in EFNB1 cause CFNS, a X-linked craniofacial disorder with an unusual manifestation pattern, in which affected females show multiple skeletal malformations whereas the genetic defect causes no or only mild abnormalities in male carriers.
Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome.
  • S. Twigg, R. Kan, A. Wilkie
  • Biology, Medicine
    Proceedings of the National Academy of Sciences of the United States of America
  • 2004
TLDR
It is proposed that in heterozygous females, patchwork loss of ephrin-B1 disturbs tissue boundary formation at the developing coronal suture, whereas in males deficient in ephin-B 1, an alternative mechanism maintains the normal boundary.
Craniofrontonasal dysplasia
TLDR
Unlike almost all other X-linked disorders, clinical expression in CFND is generally much more severe in females than in males, and one of the severely affected cases is a male.
Craniofrontonasal syndrome: study of 41 patients.
Of 41 patients with craniofrontonasal syndrome, 35 were female and 6 were male. Although most cases were sporadic, 7 familial instances were found. Craniofrontonasal syndrome represents a unique,
Eph receptors and ephrins.
  • J. Himanen, D. Nikolov
  • Biology, Chemistry
    The international journal of biochemistry & cell biology
  • 2003
Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity.
TLDR
A family of cell surface-bound ligands exhibiting distinct, but overlapping, specificities for these EPH-related kinases was identified, suggesting that they require direct cell-to-cell contact to activate their receptors.
Eph receptors and ephrins: effectors of morphogenesis.
TLDR
The role of Eph and ephrin signalling in the formation of segmented structures, in the control of axon guidance and cell migration and in the development of the vasculature is reviewed.
Craniofrontonasal syndrome and diaphragmatic hernia.